Thoraxklinik am Universitatsklinikum Heidelberg
Heidelberg, D-69126, Germany
NCT Number: NCT00684892
The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments in emphysema patients prior to endobronchial lung volume reduction (ELVR).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Heidelberg, D-69126, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of airway flow and pressure
Time frame: Until end of study procedure
Time frame: During procedure and up 1 week post procedure
Pulmonx Corporation
Industry
A Safety and Feasibility Study of the Chartis System in Subjects With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02022683
COPD, Chronic Disease
Ghent, Belgium
View Trial DetailsNCT00825578
Heterogeneous Emphysema
London, United Kingdom
View Trial DetailsNCT06642038
Heterogeneous Emphysema
View Trial DetailsNCT05567562
COPD, Chronic Disease
Boston, Massachusetts, United States
View Trial Details